VERA — Vera Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
Brief: Vera Therapeutics Appoints Jason S. Carter As Chief Legal Officer
Brief: Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Vera Therapeutics Q3 EPS USD -0.85 Vs. IBES Estimate USD -0.66
Brief: Vera Therapeutics Prices Public Offering Of 7.1 Mln Shares At $42.00 Per Share
Vera Therapeutics slips after unveiling $300 mln stock offering
Brief: Vera Therapeutics Files For Mixed Shelf Offering
Brief: Vera Therapeutics Announces Proposed Public Offering Of Class A Common Stock
Vera jumps on additional mid-stage study data for kidney disease drug
Brief: Vera Therapeutics Says ORIGIN Phase 2b Trial Met Primary And Secondary Endpoints With Significant Proteinuria Reductions
U.S. RESEARCH ROUNDUP-Commercial Metals, M&T Bank, Simon Property
Vera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Vera Therapeutics Q2 EPS USD -0.62 Vs. IBES Estimate USD -0.56
Vera Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Vera Therapeutics Announces Appointment Of Industry Veteran David Johnson As Chief Operating Officer
U.S. RESEARCH ROUNDUP-Connectone Bancorp, Hormel Foods, UMB Financial
Vera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Vera Therapeutics Q1 EPS USD -0.56 Vs. IBES Estimate USD -0.53